Respimat
Jump to navigation
Jump to search
 | This article needs to be updated. (August 2018) |
 | This article includes a list of references, related reading or external links, but its sources remain unclear because it lacks inline citations. (December 2010) (Learn how and when to remove this template message) |
Respimat, also known as Respimat Soft Mist Inhaler, is a drug delivery device used for the treatment of asthma, chronic obstructive pulmonary disease (COPD), and other respiratory conditions.
Its developer, Boehringer Ingelheim, is currently[when?] conducting approved in the U.S. with a variety of their products, such as Spiriva (tiotropium bromide) and Combivent (ipratropium bromde/albuterol).
References[edit]
Sources[edit]
-solution.jpg)
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
